|
Category: food additive and cosmetic agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Soluble in: |
| | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-mouse LD50 9800 mg/kg GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE
GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 573, 1972.
intravenous-mouse LD50 4980 mg/kg Kiso to Rinsho. Clinical Report. Vol. 6, Pg. 433, 1972.
oral-mouse LD50 > 10000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 573, 1972.
intraperitoneal-rat LD50 2900 mg/kg BEHAVIORAL: EXCITEMENT
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 573, 1972.
intravenous-rat LD50 > 3125 mg/kg Drugs in Japan Vol. -, Pg. 413, 1990.
oral-rat LD50 > 10000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 573, 1972.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 > 10000 mg/kg GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE
GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 573, 1972.
subcutaneous-rat LD50 3700 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: EXCITEMENT Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 573, 1972.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | food additive and cosmetic agents |
| Recommendation for sodium chondroitin sulfate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for sodium chondroitin sulfate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| EPI System: | View |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 45357307 |
| National Institute of Allergy and Infectious Diseases: | Data |
| | sodium;(2R,3R,4R,5S,6S)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-oxidooxysulfonyloxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid |
| Chemidplus: | 0009082079 |
References:
| | sodium;(2R,3R,4R,5S,6S)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-oxidooxysulfonyloxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 45357307 |
| Pubchem (sid): | 135302028 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | chondroitin, hydrogen sulfate, sodium salt | | | sodium;(2R,3R,4R,5S,6S)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-oxidooxysulfonyloxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid |
Articles:
|